Xermelo (Telotristat Ethyl)
- Name: XERMELO
- Generic Name: Telotristat ethyl
- Strength: tablet of 250mg
- Manufactured: Lexicon Pharmaceuticals, Inc.
Xermelo (telotristat ethyl) is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Recommended Dosage:
The recommended dosage of Xermelo in adult patients is 250 mg three times daily for patients whose diarrhea is inadequately controlled by SSA therapy. Take this therapeutic drug with food. When short-acting octreotide is used in combination with Xermelo, administer short-acting octreotide at least 30 minutes after administering Xermelo.
If any dose is missed, take the next scheduled dose at the regular time. It is not recommended to take 2 doses at the same time to make up for a missed dose. Discontinue treatment if severe constipation develops.
- Treatment with Xermelo 250 mg may worsen constipation in some patients. Monitor bowel habits regularly throughout therapy. Increase fluids, fiber, and physical activity if advised by your healthcare provider. Report serious abdominal pain, persistent constipation, or bowel obstruction symptoms immediately for medical evaluation and treatment.
- Serious allergic reactions to telotristat may develop rarely. Stop treatment and seek immediate help in case rash, dizziness, itching, swelling, or breathing difficulty occurs. Inform healthcare professionals about prior drug allergies before starting treatment to reduce risk and ensure safe use.
- The use of this medicine during pregnancy may cause harm to the unborn baby. Use only if clearly required and prescribed by a clinician. Discuss pregnancy plans, effective contraception, and potential risks before starting treatment to ensure informed medical decisions for patient safety.
- Telotristat may pass into human breast milk and could affect a nursing infant. Breastfeeding is not advised during this treatment and for some time after stopping. Consult your healthcare professional to discuss alternative feeding options and infantsafety before making final decisions.
- Safety and effectiveness of this medicine in pediatric patients have not been established. This drug is not approved for children. Use in pediatric populations should occur only within clinical studies or when clearly prescribed by a specialist with appropriate medical oversight.
What documents are required to import XERMELO to India?
XERMELO (telotristat ethyl) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patient ID proof (issued by the government of India)
How does the order get confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from the Doctor
- Import permit if applicable
Is XERMELO available in India?
XERMELO (telotristat ethyl tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input
- On the availability of Xermelo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
- On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
- Xermelo price in India.
- Finding Genuine and reliable sources from the USA, Canada,
- Europe, and Australia
Ensuring 100% transparency.
XERMELO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of XERMELO (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).
Please contact +91-9810469557 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Xermelo cost in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network can source XERMELO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Xermelo®?
Telotristat ethyl is the Generic Name for the trade name drug Xermelo®.
What is the Manufacturer’s Name of Xermelo®?
Xermelo® is manufactured by Lexicon Pharmaceuticals, Inc.
Is Xermelo approved by the FDA?
Yes. Xermelo is approved by the FDA. date of first approval: February 28, 2017.
What is the dosage and form of Xermelo® supplied?
Xermelo is supplied as Tablets: 250 mg of Telotristat ethyl for oral use.
What are the most common side effects of Xermelo® 250 mg Tablets?
The most commonly reported side effects of Xermelo® are headache, nausea, increased GGT, depression, flatulence, peripheral edema, decreased appetite, and pyrexia.
How does Xermelo Import in India work?
Xermelo Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.
How much does Xermelo® Tablet 250 mg cost in India?
Xermelo® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Xermelo prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Xermelo cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.
Can Xermelo® 250 mg Tablets be available in SAARC countries?
Apart from Gulf countries, Xermelo® 250 mg can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Xermelo® tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.
Is it safe to buy Xermelo® 250 mg Tablets online in India?
Yes, one can buy Xermelo in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Xermelo® tablets through legal channels.
What are the storage conditions of Xermelo® 250 mg Tablets?
Store Xermelo 250 mg oral tablets at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.